Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

19
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
19
Neural Regulation01:37

Neural Regulation

34.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.6K
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Peripheral Nervous System: Ganglia and Nerves01:24

Peripheral Nervous System: Ganglia and Nerves

7.8K
The Peripheral Nervous System (PNS) is a crucial component of the body's neural network, extending beyond the central nervous system (CNS) to bridge the gap between the CNS and the external environment. It encompasses nerves, ganglia, and sensory receptors.
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
7.8K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

2.1K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining Relapse and Disease Activity in Neurosarcoidosis: A Systematic Review and Proposed Framework.

Neurology. Clinical practice·2026
Same author

TEAM Sarcoidosis: Creating a Multidisciplinary Care Team for Complex Clinical Management.

Chest·2025
Same author

A Multi-Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future Directions.

Annals of clinical and translational neurology·2025
Same author

Working Together in Sarcoidosis: Experience and Impact of a Formalized Multidisciplinary Discussion.

Annals of the American Thoracic Society·2025
Same author

Neurosarcoidosis and Neurologic Complications of Sarcoidosis Treatment.

Clinics in chest medicine·2024
Same author

The distribution of acquired peripheral nerve injuries associated with severe COVID-19 implicate a mechanism of entrapment neuropathy: a multicenter case series and clinical feasibility study of a wearable, wireless pressure sensor.

Journal of neuroengineering and rehabilitation·2022
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
03:53

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

672

Neurosarcoidosis.

Jinny O Tavee, Barney J Stern

    Continuum (Minneapolis, Minn.)
    |June 4, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Neurosarcoidosis diagnosis is improving with advanced imaging like FDG-PET scans and less invasive biopsies. Treatment now often combines TNF-α antagonists with steroids for severe cases.

    More Related Videos

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
    08:57

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

    Published on: May 17, 2024

    3.1K
    Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
    09:43

    Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

    Published on: October 14, 2019

    6.2K

    Related Experiment Videos

    Last Updated: Apr 28, 2026

    An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
    03:53

    An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

    Published on: October 10, 2025

    672
    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
    08:57

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

    Published on: May 17, 2024

    3.1K
    Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
    09:43

    Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

    Published on: October 14, 2019

    6.2K

    Area of Science:

    • Neurology
    • Immunology
    • Radiology

    Background:

    • Neurosarcoidosis presents with diverse clinical symptoms.
    • Diagnosis of neurosarcoidosis remains challenging.

    Purpose of the Study:

    • To provide an update on the evaluation and treatment of neurosarcoidosis.
    • To highlight recent advancements in diagnostic and therapeutic strategies.

    Main Methods:

    • Review of current literature on neurosarcoidosis.
    • Discussion of advanced imaging techniques (FDG-PET, high-resolution CT).
    • Evaluation of minimally invasive biopsy methods (endobronchial ultrasound-guided transbronchial needle aspiration).

    Main Results:

    • Expanded clinical manifestations include small fiber neuropathy.
    • FDG-PET and CT scans improve systemic sarcoidosis detection.
    • Endobronchial ultrasound offers less invasive tissue confirmation.
    • Treatment commonly involves TNF-α antagonists, corticosteroids, and cytotoxic agents for severe disease.

    Conclusions:

    • Recent diagnostic advances aid in identifying neurosarcoidosis.
    • Evolving treatment strategies offer improved management options.
    • These advancements benefit both patients and clinicians managing this complex condition.